Integrated Pharmaceuticals Expands its Operations Related to Biologics and Biopharmaceutical Research and Production to Fitchburg, MA. 10/8/2003 12:28:00 PM
- PR Newswire

BOSTON, Oct 8, 2003 /PRNewswire-FirstCall via COMTEX/ -- Integrated Pharmaceuticals, Inc. (IntePharm) (INTP) announced today that it is expanding its operations to a new facility in Fitchburg, MA. The new facility will be able to accommodate IntePharm's additional therapeutic research programs including process development and production of biologics as well as biopharmaceuticals, said Dr. Chinmay Chatterjee, President and Chief Executive Officer of Integrated Pharmaceuticals, Inc.

Dr. Chatterjee said that this new facility would help Integrated Pharmaceuticals to expedite its current biopharmaceuticals manufacturing activities including the construction of a cGMP manufacturing facility under FDA guidelines.

Dr. Chatterjee continued, that the Company's presence in two locations; Boston and Fitchburg would help Integrated Pharmaceuticals to attract top talents from the Boston, Cambridge and Worcester area for its involvement in cutting edge research related to drug discovery, process development as well as manufacturing of biopharmaceuticals and biologics. IntePharm will post several new open positions at its website shortly for both locations.

Details of the new facility and its location including the terms and conditions of occupancy will be announced shortly. Dr. Chatterjee also added that the new facility would help the company to expand its customer base for addition of resources for biotech research and manufacturing.

About the company

Integrated Pharmaceuticals, Inc. is an emerging pharmaceuticals and biotechnology company that discovers, develops, manufactures and markets pharmaceuticals, specialty chemicals and ingredients for significant unmet medical and commercial needs. Integrated Pharmaceuticals, Inc. is involved in the application of combined approach of emerging fields of research of advanced bioprocess engineering, computer simulation science and metabolic engineering. The Company utilizes these fields of research for the production of recombinant DNA derived and small molecule drugs for therapeutic uses. IntePharm's clinically active compounds have applications for the treatment of chronic diseases. The company has several market ready products in the pipeline for commercialization in the immediate future.

For further information please contact Dr. Chinmay Chatterjee, Integrated Pharmaceuticals, Inc. at (978) 696-0020 or visit company's website at http://www.intepharm.com

SOURCE Integrated Pharmaceuticals, Inc.

Dr. Chinmay Chatterjee of Integrated Pharmaceuticals, Inc., +1-
978-696-0020

www.intepharm.com
Copyright (C) 2003 PR Newswire. All rights reserved.